Blood pressure monitor maker Omron Healthcare has gotten approval for a new home monitor that can detect atrial fibrillation.
OMRON Healthcare has secured De Novo authorisation from the US Food and Drug Administration (FDA) for new home blood pressure ...
In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...
The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...
OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...
The global thermometer market, valued at approximately USD 1.5 billion in 2021, is on track to experience significant growth ...
The Manila Times on MSN4d
Cool under pressureOmron's resilience through the pandemic was thanks to our mission of empowering health and reducing risk for Filipinos. Our ...
China’s economic stagnation is forcing control system manufacturer Omron Corp. to slash 2,000 jobs in Japan and overseas. The company announced Feb. 26 it will seek voluntary retirement of about ...
Mean achieved blood pressure in the two groups was 120.6 mm Hg in the intensive-treatment group and 132.1 mm Hg in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback